Literature DB >> 19768369

Size frequency distribution of the beta-amyloid (abeta) deposits in dementia with Lewy bodies with associated Alzheimer's disease pathology.

Richard A Armstrong1, Nigel J Cairns.   

Abstract

The objective is to study beta-amyloid (Abeta) deposition in dementia with Lewy bodies (DLB) with Alzheimer's disease (AD) pathology (DLB/AD). The size frequency distributions of the Abeta deposits were studied and fitted by log-normal and power-law models. Patients were ten clinically and pathologically diagnosed DLB/AD cases. Size distributions had a single peak and were positively skewed and similar to those described in AD and Down's syndrome. Size distributions had smaller means in DLB/AD than in AD. Log-normal and power-law models were fitted to the size distributions of the classic and diffuse deposits, respectively. Size distributions of Abeta deposits were similar in DLB/AD and AD. Size distributions of the diffuse deposits were fitted by a power-law model suggesting that aggregation/disaggregation of Abeta was the predominant factor, whereas the classic deposits were fitted by a log-normal distribution suggesting that surface diffusion was important in the pathogenesis of the classic deposits.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19768369      PMCID: PMC2809796          DOI: 10.1007/s10072-009-0135-6

Source DB:  PubMed          Journal:  Neurol Sci        ISSN: 1590-1874            Impact factor:   3.307


  25 in total

1.  Controlling polymerization of beta-amyloid and prion-derived peptides with synthetic small molecule ligands.

Authors:  P Kuner; B Bohrmann; L O Tjernberg; J Näslund; G Huber; S Celenk; F Grüninger-Leitch; J G Richards; R Jakob-Roetne; J A Kemp; C Nordstedt
Journal:  J Biol Chem       Date:  2000-01-21       Impact factor: 5.157

2.  Morphological study of amyloid fibrils and preamyloid deposits in the brain with Alzheimer's disease.

Authors:  T Miyakawa; S Katsuragi; K Yamashita; K Ohuchi
Journal:  Acta Neuropathol       Date:  1992       Impact factor: 17.088

Review 3.  The interface between Alzheimer's disease, normal aging, and related disorders.

Authors:  R A Armstrong
Journal:  Curr Aging Sci       Date:  2008-07

4.  Early senile plaques in Down's syndrome brains show a close relationship with cell bodies of neurons.

Authors:  D Allsop; S I Haga; C Haga; S I Ikeda; D M Mann; T Ishii
Journal:  Neuropathol Appl Neurobiol       Date:  1989 Nov-Dec       Impact factor: 8.090

5.  Cortical Lewy body dementia: clinical features and classification.

Authors:  W R Gibb; P J Luthert; I Janota; P L Lantos
Journal:  J Neurol Neurosurg Psychiatry       Date:  1989-02       Impact factor: 10.154

6.  Amyloid-associated proteins alpha 1-antichymotrypsin and apolipoprotein E promote assembly of Alzheimer beta-protein into filaments.

Authors:  J Ma; A Yee; H B Brewer; S Das; H Potter
Journal:  Nature       Date:  1994-11-03       Impact factor: 49.962

7.  Alzheimer's disease and Down's syndrome: sharing of a unique cerebrovascular amyloid fibril protein.

Authors:  G G Glenner; C W Wong
Journal:  Biochem Biophys Res Commun       Date:  1984-08-16       Impact factor: 3.575

Review 8.  Quantifying the pathology of neurodegenerative disorders: quantitative measurements, sampling strategies and data analysis.

Authors:  R A Armstrong
Journal:  Histopathology       Date:  2003-06       Impact factor: 5.087

9.  Association of apolipoprotein E allele epsilon 4 with late-onset familial and sporadic Alzheimer's disease.

Authors:  A M Saunders; W J Strittmatter; D Schmechel; P H George-Hyslop; M A Pericak-Vance; S H Joo; B L Rosi; J F Gusella; D R Crapper-MacLachlan; M J Alberts
Journal:  Neurology       Date:  1993-08       Impact factor: 9.910

10.  Quantitative analysis of senile plaques in Alzheimer disease: observation of log-normal size distribution and molecular epidemiology of differences associated with apolipoprotein E genotype and trisomy 21 (Down syndrome).

Authors:  B T Hyman; H L West; G W Rebeck; S V Buldyrev; R N Mantegna; M Ukleja; S Havlin; H E Stanley
Journal:  Proc Natl Acad Sci U S A       Date:  1995-04-11       Impact factor: 11.205

View more
  5 in total

1.  Digital pathology and image analysis for robust high-throughput quantitative assessment of Alzheimer disease neuropathologic changes.

Authors:  Janna Hackett Neltner; Erin Lynn Abner; Frederick A Schmitt; Stephanie Kay Denison; Sonya Anderson; Ela Patel; Peter T Nelson
Journal:  J Neuropathol Exp Neurol       Date:  2012-12       Impact factor: 3.685

2.  Aβ exacerbates α-synuclein-induced neurotoxicity through impaired insulin signaling in α-synuclein-overexpressed human SK-N-MC neuronal cells.

Authors:  Ching-Chi Chang; Hsin-Hua Li; Yen-Ting Chang; Ying-Jui Ho; Ling-Jia Hsieh; Pai-Yi Chiu; Yu-Shih Cheng; Chih-Li Lin; Te-Jen Lai
Journal:  CNS Neurosci Ther       Date:  2017-11-01       Impact factor: 5.243

3.  Cerebrospinal fluid biomarkers for dementia with lewy bodies.

Authors:  Elizabeta B Mukaetova-Ladinska; Rachael Monteith; Elaine K Perry
Journal:  Int J Alzheimers Dis       Date:  2010-10-17

4.  Arteriolosclerosis that affects multiple brain regions is linked to hippocampal sclerosis of ageing.

Authors:  Janna H Neltner; Erin L Abner; Steven Baker; Frederick A Schmitt; Richard J Kryscio; Gregory A Jicha; Charles D Smith; Eleanor Hammack; Walter A Kukull; Willa D Brenowitz; Linda J Van Eldik; Peter T Nelson
Journal:  Brain       Date:  2013-11-21       Impact factor: 13.501

5.  Use of Ceftriaxone in Treating Cognitive and Neuronal Deficits Associated With Dementia With Lewy Bodies.

Authors:  Ying-Jui Ho; Mei-Shiuan Shen; Chun-Hwei Tai; Hsin-Hua Li; Jian-Horng Chen; Wen-Chieh Liao; Pai-Yi Chiu; I-Yen Lee; Chih-Li Lin; Ching-Sui Hung
Journal:  Front Neurosci       Date:  2019-05-24       Impact factor: 4.677

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.